Single-center retrospective cohort of 7,181 primary hip and knee replacements (2002–2008) examining whether diabetes, obesity, and preoperative hyperglycemia independently predict one-year periprosthetic joint infection, using prospective surveillance data and multivariate logistic regression adjusted for age, sex, ASA score, joint replaced, BMI, and diabetic status.
When your arthroplasty patient has both morbid obesity and diabetes, their PJI risk approaches 1 in 10 — counsel accordingly and consider whether optimization (weight loss, glycemic control, or even bariatric surgery) should precede the joint replacement.
Screen all obese preoperative patients for occult hyperglycemia: a fasting glucose ≥6.9 mmol/L may flag undiagnosed diabetics who carry similarly elevated risk.
Single-center retrospective cohort of 7,181 primary hip and knee replacements (2002–2008) examining whether diabetes, obesity, and preoperative hyperglycemia independently predict one-year periprosthetic joint infection, using prospective surveillance data and multivariate logistic regression adjusted for age, sex, ASA score, joint replaced, BMI, and diabetic status.
When your arthroplasty patient has both morbid obesity and diabetes, their PJI risk approaches 1 in 10 — counsel accordingly and consider whether optimization (weight loss, glycemic control, or even bariatric surgery) should precede the joint replacement.
Screen all obese preoperative patients for occult hyperglycemia: a fasting glucose ≥6.9 mmol/L may flag undiagnosed diabetics who carry similarly elevated risk.